Intuitive Surgical stock stabilizes after sharp 2026 pullback as new cardiac use expands da Vinci 5

{
  "signal_id": "5102a489-a93b-245a-a871-522b94ae8d4e",
  "signal_type": "news",
  "signal_subtype": "launches",
  "detected_at": "2026-08-18T15:08:59+00:00",
  "company": {
    "name": "Intuitive Surgical",
    "domain": "intuitive.com"
  },
  "data": {
    "url": "https://www.ad-hoc-news.de/boerse/news/corporate-news/intuitive-surgical-stock-stabilizes-after-sharp-2026-pullback-as-new/69965317",
    "title": "Intuitive Surgical stock stabilizes after sharp 2026 pullback as new cardiac use expands da Vinci 5 - AD HOC NEWS",
    "excerpt": "Intuitive Surgical Inc. (US46120E6023) stock has retreated to the high-$390 range as of August 17, 2026, leaving the robotic-surgery pioneer more than 30 percent below its level at the start of the year even as procedure volumes continue to grow in double digits. Per recent market data as of August 17, 2026, Intuitive Surgical shares closed at $390.33 on the Nasdaq, down 31.1 percent year to date from $566.36, underscoring the extent of the 2026 drawdown despite ongoing operational expansion in its da Vinci franchise. This marks a sharp reset in valuation for a company whose stock has historically compounded in the mid-teens annually, creating a different entry and risk profile for investors assessing the balance between competition, regulatory momentum, and long-term procedure growth. Market data compiled on August 18, 2026 show Intuitive Surgical trading around $390 per share, with recent closes reported between $390.24 and $394.51, reflecting modest day-to-day volatility but a clear step down from early-2026 levels above $560. According to a detailed stock overview, Intuitive Surgical shares closed at $390.33 on August 17, 2026, representing a decrease of 31.1 percent from $566.36 at the beginning of 2026, a quantified decline that highlights how sentiment toward medtech and surgical devices has reset over the past months. Another market summary notes Intuitive Surgical...",
    "product": "da Vinci 5",
    "summary": "Intuitive Surgical has received FDA clearance for its da Vinci 5 system to be used in several cardiac procedures, expanding its application into a new category of robot-assisted interventions in cardiology.",
    "planning": false,
    "image_url": "https://mdb.ad-hoc-news.de/bild/bild-2704301_1920_1080.webp",
    "confidence": 0.95,
    "product_data": {
      "name": "da Vinci 5",
      "full_text": "da Vinci 5 system",
      "fuzzy_match": false,
      "release_type": "system"
    },
    "product_tags": [
      "medical",
      "general_technology"
    ],
    "published_at": "2026-08-18T15:08:59Z",
    "article_sentence": "According to a detailed product and regulatory update, Intuitive Surgical has received FDA clearance for several cardiac procedures on the da Vinci 5 system using non-force feedback instruments, opening up a new category of robot-assisted interventions in cardiology."
  }
}

curl https://signals.autobound.ai/v1/signals/5102a489-a93b-245a-a871-522b94ae8d4e \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"intuitive.com","limit":20}'